These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10551656)

  • 1. Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient.
    Zoppo A; Faggiotto A; Redaelli L; Campi S; Catapano AL
    Transplantation; 1999 Oct; 68(8):1211. PubMed ID: 10551656
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.
    Satyanarayana PS; Chopra K
    Ren Fail; 2002 May; 24(3):259-74. PubMed ID: 12166693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant.
    Hawwa AF; McElnay JC
    Expert Opin Drug Saf; 2011 Jan; 10(1):9-22. PubMed ID: 20629603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe symptomatic hyponatremia--an uncommon presentation of tacrolimus nephrotoxicity.
    Bagchi S; Husain Zaidi S; Prasad Mathur R
    Nephrol Dial Transplant; 2011 Jun; 26(6):2042-4. PubMed ID: 21454354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus-Induced Cholestatic Hepatitis in a Patient With Liver Transplant.
    González-Diéguez ML; Viso Vidal D; Mendoza Pacas GE; Houghton RF
    Transplantation; 2018 Oct; 102(10):e454-e456. PubMed ID: 29979348
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.
    Katari SR; Magnone M; Shapiro R; Jordan M; Scantlebury V; Vivas C; Gritsch A; McCauley J; Starzl T; Demetris AJ; Randhawa PS
    Clin Transplant; 1997 Jun; 11(3):237-42. PubMed ID: 9193849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-Associated Jaundice.
    Pandey N; Gupta AK; Gupta S
    Am J Ther; 2018; 25(6):e723-e725. PubMed ID: 29672330
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent oral ulcers and diarrhea in a renal transplant patient. Behcet's disease (associated with IgA nephropathy) and acute tacrolimus nephrotoxicity.
    Lai KN; Lai AS; Yap DY; Ng MM
    Kidney Int; 2009 Dec; 76(11):1211-2. PubMed ID: 19910956
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients.
    Dansirikul C; Staatz CE; Duffull SB; Taylor PJ; Lynch SV; Tett SE
    J Clin Pharm Ther; 2006 Feb; 31(1):17-25. PubMed ID: 16476116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus-induced nephrotoxicity and genetic variability: a review.
    Gijsen VM; Madadi P; Dube MP; Hesselink DA; Koren G; de Wildt SN
    Ann Transplant; 2012; 17(2):111-21. PubMed ID: 22743729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior reversible encephalopathy syndrome in the Intensive Care Unit after liver transplant: a comparison of our experience with the existing literature.
    Lunardi N; Saraceni E; Boccagni P; Segato M; Bortolato A; Manara R; Rossi S; Ori C
    Minerva Anestesiol; 2012 Jul; 78(7):847-50. PubMed ID: 21701444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.
    Dopazo C; Bilbao I; Lázaro JL; Sapisochin G; Caralt M; Blanco L; Castells L; Charco R
    Transplant Proc; 2009 Apr; 41(3):1021-4. PubMed ID: 19376416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CARI guidelines. Calcineurin inhibitors in renal transplantation: nephrotoxicity and calcineurin inhibitors.
    Coates PT;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S85-7. PubMed ID: 17316286
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing contrast nephropathy in catheter laboratory.
    Fung JW; Szeto CC; Yu CM
    Heart; 2007 Jun; 93(6):654-5. PubMed ID: 17502647
    [No Abstract]   [Full Text] [Related]  

  • 15. The nephrotoxicity of immunosuppressive drugs.
    Bennett WM
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S3-7. PubMed ID: 7540121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine Profile in Calcineurin Inhibitor-Induced Chronic Nephrotoxicity in Chinese Liver Transplant Recipients.
    Tang J; Shi Y; Deng R; Zhang J; An Y; Li Y; Wang L
    Transplant Proc; 2016 Oct; 48(8):2756-2762. PubMed ID: 27788813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients.
    Shi Y; Li Y; Tang J; Zhang J; Zou Y; Cai B; Wang L
    Gene; 2013 Jan; 512(2):226-31. PubMed ID: 23107770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction between tacrolimus and theophylline in a renal transplant recipient: a case report].
    Gaïes E; Trabelsi S; Salouage I; Jebabli N; Charfi R; Lakhal M; Klouz A
    Therapie; 2011; 66(6):553-4. PubMed ID: 22186080
    [No Abstract]   [Full Text] [Related]  

  • 19. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients.
    Schmidt LE; Rasmussen A; Kirkegaard P; Dalhoff K
    Transplantation; 2003 Jul; 76(2):358-63. PubMed ID: 12883193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.